A Novel Electrocardiographic Marker to Predict the Development of Preeclampsia: Frontal QRS-T Angle-A Prospective Pilot Study

一种预测先兆子痫发生的新型心电图标志物:额面QRS-T角——一项前瞻性试点研究

阅读:1

Abstract

Background and Objectives: Preeclampsia, a pregnancy-induced hypertensive disorder, shares cardiovascular characteristics in etiology, prognosis, and fetomaternal risks. Electrocardiography plays a pivotal role in assessing cardiovascular risks. Beyond conventional predictors, identifying easily obtainable and reproducible electrocardiographic markers may significantly contribute to the early identification of individuals at risk of preeclampsia. In this study, we aimed to investigate the value of the Frontal QRS-T angle and other electrocardiographic parameters in predicting the development of preeclampsia. Materials and Methods: A total of 62 pregnant patients diagnosed with preeclampsia and 50 healthy pregnant patients as the control group were included in this study. The first- and third-trimester electrocardiographic parameters were compared within groups and between groups. Results: The Frontal QRS-T angle was significantly elevated in patients with preeclampsia compared to the controls (55.0 ± 40.8 vs. 19.5 ± 15.1; p = 0.002). The first-trimester Frontal QRS-T angles in the patients with preeclampsia were higher than those of the controls (29.5 ± 25.0 vs. 15.3 ± 11.5; p = 0.015). A high Frontal QRS-T angle independently marked preeclampsia development in antenatal and late pregnancy (p = 0.003 and p = 0.042, respectively). The diagnostic accuracy of the Frontal QRS-T angle in predicting preeclampsia surpassed other electrocardiographic parameters. Conclusions: This study shows that the Frontal QRS-T angle may be a candidate to be an independent predictor for the development of preeclampsia. In this context, the Frontal QRS-T angle, which is an electrocardiographic parameter, seems promising.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。